Bradley Foster & Sargent Inc Pfizer Inc Transaction History

Bradley Foster & Sargent Inc

$5.77 Billion
Q4 2024

A detailed history of Bradley Foster & Sargent Inc transactions in Pfizer Inc stock. As of the latest transaction made, Bradley Foster & Sargent Inc holds 423,230 shares of PFE stock, worth $10.8 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

423,230

Previous 284,015 49.02%

Holding current value

$10.8 Million

Previous $8.22 Million 36.61%

% of portfolio

0.19%

Previous 0.14%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 03, 2025	BUY	$24.8 - $30.19 $3.45 Million - $4.2 Million	139,215 Added 49.02%	423,230 $11.2 Million
Q3 2024 Nov 04, 2024	BUY	$27.7 - $31.39 $357,191 - $404,774	12,895 Added 4.76%	284,015 $8.22 Million
Q2 2024 Aug 09, 2024	BUY	$25.26 - $29.6 $211,552 - $247,900	8,375 Added 3.19%	271,120 $7.59 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $515,884 - $592,399	-19,926 Reduced 7.05%	262,745 $7.29 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $1.25 Million - $1.62 Million	-47,802 Reduced 14.46%	282,671 $8.14 Million
Q2 2023 Aug 08, 2023	BUY	$36.12 - $41.79 $366,509 - $424,043	10,147 Added 3.17%	330,473 $12.1 Million
Q1 2023 May 08, 2023	SELL	$39.39 - $51.28 $735,726 - $957,807	-18,678 Reduced 5.51%	320,326 $13.1 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $144,789 - $189,006	-3,468 Reduced 1.01%	339,004 $17.4 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $135,174 - $165,014	-3,089 Reduced 0.89%	342,472 $15 Million
Q2 2022 Aug 11, 2022	BUY	$46.53 - $55.17 $211,664 - $250,968	4,549 Added 1.33%	345,561 $18.1 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $1.29 Million - $1.6 Million	28,226 Added 9.02%	341,012 $17.7 Million
Q4 2021 Mar 11, 2022	BUY	$41.32 - $61.25 $202,468 - $300,125	4,900 Added 1.59%	312,786 $18.5 Million
Q3 2021 Nov 10, 2021	BUY	$39.25 - $50.42 $15,307 - $19,663	390 Added 0.13%	307,886 $13.2 Million
Q2 2021 Aug 19, 2021	SELL	$35.91 - $40.68 $175,133 - $198,396	-4,877 Reduced 1.56%	307,496 $12 Million
Q1 2021 Apr 26, 2021	SELL	$33.49 - $37.77 $1.49 Million - $1.69 Million	-44,619 Reduced 12.5%	312,373 $11.3 Million
Q4 2020 Feb 11, 2021	BUY	$33.47 - $42.56 $195,531 - $248,635	5,842 Added 1.66%	356,992 $13.1 Million
Q3 2020 Oct 26, 2020	SELL	$31.75 - $37.25 $133,731 - $156,897	-4,212 Reduced 1.19%	351,150 $12.9 Million
Q1 2020 May 07, 2020	SELL	$27.03 - $38.62 $377,663 - $539,598	-13,972 Reduced 3.78%	355,362 $11.6 Million
Q4 2019 Jan 29, 2020	SELL	$32.92 - $37.36 $84,176 - $95,529	-2,557 Reduced 0.69%	369,334 $14.5 Million
Q3 2019 Oct 30, 2019	SELL	$32.49 - $42.13 $279,511 - $362,444	-8,603 Reduced 2.26%	371,891 $13.4 Million
Q2 2019 Aug 08, 2019	SELL	$36.98 - $41.52 $466,058 - $523,276	-12,603 Reduced 3.21%	380,494 $16.5 Million
Q1 2019 May 02, 2019	SELL	$37.5 - $41.2 $275,400 - $302,572	-7,344 Reduced 1.83%	393,097 $16.7 Million
Q4 2018 Jan 30, 2019	SELL	$38.47 - $43.86 $4,154 - $4,736	-108 Reduced 0.03%	400,441 $17.5 Million
Q3 2018 Oct 31, 2018	BUY	$34.47 - $41.81 $185,896 - $225,481	5,393 Added 1.36%	400,549 $17.7 Million
Q2 2018 Jul 31, 2018	SELL	$32.98 - $35.16 $39,279 - $41,875	-1,191 Reduced 0.3%	395,156 $14.3 Million
Q1 2018 May 07, 2018	BUY	$31.91 - $37.02 $188,556 - $218,751	5,909 Added 1.51%	396,347 $14.1 Million
Q4 2017 Feb 06, 2018	SELL	$33.26 - $35.29 $105,467 - $111,904	-3,171 Reduced 0.81%	390,438 $14.1 Million
Q3 2017 Nov 03, 2017	BUY	$31.0 - $34.15 $12.2 Million - $13.4 Million	393,609	393,609 $14.1 Million

Others Institutions Holding PFE

# of Institutions

3,329

Shares Held

3.68B

Call Options Held

101M

Put Options Held

131M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $143B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bradley Foster & Sargent Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bradley Foster & Sargent Inc with notifications on news.

Account

Bradley Foster & Sargent Inc Pfizer Inc Transaction History